 |
|
|
|
|
|
|
|
 |
Results for 'The Pharmaceutical Market: Israel' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
The Pharmaceutical Market: Israel
|
July 2008 |
£595 |
100 % |
Pricing & Reimbursement of Medicines in the United Kingdom
Understanding the pharmaceutical market in the healthcare system
|
June 2005 |
£450 |
70 % |
U.S. Bio-Computing IT Market + Pharmaceutical Companies, The Fusion of Computing and Drug Discovery
Bio-Computing + Pharmaceutical Companies,
The Fusion of Computing and Drug Discovery
Technologies, Opportunities and Market
|
January 2001 |
£1840 |
61.6 % |
The Pharmaceutical Market: Pakistan
|
November 2007 |
£595 |
50 % |
The Pharmaceutical Market: Colombia
|
August 2006 |
£595 |
50 % |
The Pharmaceutical Market: Taiwan
|
March 2007 |
£595 |
50 % |
The Pharmaceutical Market: Egypt
|
February 2006 |
£595 |
50 % |
The Pharmaceutical Market
Bangladesh
|
May 2008 |
£595 |
50 % |
The Pharmaceutical Market: Bangladesh
|
April 2007 |
£595 |
50 % |
The Pharmaceutical Market
Taiwan
|
May 2008 |
£595 |
50 % |
The Pharmaceutical Market: Indonesia
|
December 2006 |
£595 |
50 % |
Indian Pharmaceutical Market, The
Challenges & Opportunities
|
February 2007 |
£595 |
50 % |
The Pharmaceutical Market: Austria
|
September 2007 |
£595 |
50 % |
The Pharmaceutical Market: Argentina
|
November 2007 |
£595 |
50 % |
The Pharmaceutical Market: Slovakia
Pharmaceuticals, Country Overviews and Healthcare
|
August 2008 |
£595 |
50 % |
The Pharmaceutical Market: Ireland
|
November 2007 |
£595 |
50 % |
The Pharmaceutical Market: Chile
|
March 2007 |
£595 |
50 % |
The Pharmaceutical Market: Canada
|
August 2007 |
£595 |
50 % |
The Pharmaceutical Market: Netherlands
Pharmaceuticals, Country Overviews and Healthcare
|
August 2008 |
£595 |
50 % |
The Pharmaceutical Market: Cuba
|
February 2007 |
£595 |
50 % |
The Pharmaceutical Market: Croatia
|
December 2006 |
£595 |
50 % |
The Pharmaceutical Market: Portugal
Pharmaceuticals, Country Overviews and Healthcare
|
August 2008 |
£595 |
50 % |
The Pharmaceutical Market: Lithuania
|
August 2007 |
£595 |
50 % |
The Pharmaceutical Market
Chile
|
May 2008 |
£595 |
50 % |
The Pharmaceutical Market: Japan
|
August 2007 |
£595 |
50 % |
The Pharmaceutical Market: Italy
|
August 2007 |
£595 |
50 % |
The Pharmaceutical Market: New Zealand
|
April 2007 |
£595 |
50 % |
The Pharmaceutical Market: Latvia
|
November 2006 |
£595 |
50 % |
The Pharmaceutical Market
Spain
|
May 2008 |
£595 |
50 % |
The Pharmaceutical Market
Czech Republic
|
May 2008 |
£595 |
50 % |
The Pharmaceutical Market: Philippines
|
March 2007 |
£595 |
50 % |
The Pharmaceutical Market
Taiwan
|
May 2008 |
£595 |
50 % |
The Pharmaceutical Market: South Africa
|
October 2007 |
£595 |
49 % |
The Pharmaceutical Market: Hong Kong
|
July 2006 |
£595 |
49 % |
The Indian Pharmaceutical Market to 2011
Competitive dynamics and major players
|
July 2007 |
£1495 |
49 % |
The Pharmaceutical Market: South Korea
Pharmaceuticals, Country Overviews and Healthcare
|
August 2008 |
£595 |
49 % |
Chinese Pharmaceutical Market Overview
Regulatory reform and the evolving healthcare market provide opportunities in china
|
November 2007 |
£2995 |
49 % |
The Pharmaceutical Market: Saudi Arabia
|
August 2007 |
£595 |
49 % |
Biologic drugs to drive pharmaceutical market growth
|
October 2006 |
£895 |
48 % |
Cardiovascular Pharmaceutical Market Trends, 2007 to 2010
Key market forecasts and growth opportunities
|
August 2007 |
£895 |
48 % |
Pharmaceutical New Product Commercialization: Preparing for Market Success
|
May 2008 |
£5360 |
48 % |
Global Endocrine Pharmaceutical Market 2005, The
2nd Edition
|
March 2005 |
£1499 |
48 % |
The US Bio-Chip Market for Pharmaceutical Drug Discovery
Technology, Strategic Alliance, Patent Dispute and Market Update - 2002
|
May 2001 |
£735 |
48 % |
The World OTC Pharmaceutical Market Analysis & Forecasts, 2008-2023
|
June 2008 |
£1499 |
47 % |
Emerging Markets Series: The Pharmaceutical Market of South Korea
|
October 2008 |
£4000 |
47 % |
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
Sales & Marketing
|
October 2007 |
£3800 |
47 % |
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
|
May 2008 |
£1499 |
47 % |
Product Relaunch Excellence: Transforming Lackluster Pharmaceutical Products into Market Success Stories
|
October 2004 |
£3120 |
46 % |
Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Serve the U.S. Market
|
February 2008 |
£2255 |
45 % |
Israel Pharmaceuticals & Healthcare
|
November 2006 |
£395 |
37 % |
Streamlining Information in the Pharmaceutical Industry with PLM (Review Report)
|
August 2007 |
£1795 |
37 % |
Israel Pharmaceuticals and Healthcare Report Q3 2008
--Israel
|
July 2008 |
£425 |
35 % |
Indian Pharmaceutical Industry
|
July 2008 |
£2280 |
35 % |
2007 Trends to Watch: Pharmaceutical Technology
|
March 2007 |
£947 |
34.5 % |
OTC pharmaceuticals market in Poland 2004-2006, The
|
March 2005 |
£1260 |
33.5 % |
World Pharmaceutical Drug Market
Sector Snapshot
|
September 2006 |
£335 |
33.5 % |
The Pharmaceutical Market Outlook to 2015
Implementing innovative, long-term strategies for sustainable future growth
|
January 2005 |
£1495 |
33 % |
Greece Pharmaceuticals & Healthcare
|
September 2007 |
£360 |
32.9 % |
Snapshots Sweden Pharmaceuticals 2005
|
December 2005 |
£150 |
32.5 % |
Offshoring Clinical Trials
(The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel)
|
November 2007 |
£2345 |
32 % |
Mexico Pharmaceuticals 2005
|
October 2005 |
£150 |
31 % |
Streamlining Information in the Pharmaceutical Industry with Product Lifecycle Management Solutions (Executive Presentation)
|
August 2007 |
£1000 |
31 % |
Brand Planning for the Pharmaceutical Industry
|
July 2004 |
£95 |
31 % |
Emerging Pharmaceutical Markets Argentina and Mexico
|
March 2008 |
£3800 |
31 % |
Eye Care in Israel
|
July 2008 |
£450 |
30.8 % |
Wound Treatments in Israel
|
July 2008 |
£450 |
30.8 % |
The Pharmaceutical Market: Norway
|
March 2006 |
£595 |
30.5 % |
Pharmaceutical Market Segmentation
Spending, Strategy and Implementation
|
June 2006 |
£2945 |
30.5 % |
Analgesics in Israel
|
July 2008 |
£450 |
30.45 % |
Digestive Remedies in Israel
|
July 2008 |
£450 |
30.45 % |
The Pharmaceutical Market: Venezuela
|
December 2007 |
£595 |
30 % |
Snapshots Italy Pharmaceuticals 2005
|
December 2005 |
£150 |
30 % |
NRT Smoking Cessation Aids in Israel
|
July 2008 |
£450 |
29.75 % |
Beyond the Blockbuster Drug
Strategies for nichebuster drugs, targeted therapies and personalized medicine.
|
February 2005 |
£1495 |
29.5 % |
The Pharmaceutical Market: Poland
|
June 2007 |
£595 |
29.5 % |
The Pharmaceutical Market: Morocco
|
June 2007 |
£595 |
29.5 % |
Snapshots France Pharmaceuticals 2005
|
January 2006 |
£150 |
29.5 % |
The Pharmaceutical Market: Mexico
|
June 2007 |
£595 |
29.5 % |
The Pharmaceutical Market: Russia
|
June 2007 |
£595 |
29.5 % |
The Pharmaceutical Market: Romania
|
July 2008 |
£595 |
29.5 % |
Vitamins And Dietary Supplements in Israel
|
July 2008 |
£450 |
29.4 % |
Medicated Skin Care in Israel
|
July 2008 |
£450 |
29.05 % |
Snapshots Germany Pharmaceuticals 2007
|
June 2007 |
£150 |
29 % |
Snapshots Germany Pharmaceuticals 2007
|
June 2007 |
£150 |
29 % |
Snapshots Sweden Pharmaceuticals 2006
|
September 2006 |
£150 |
29 % |
Snapshots Germany Pharmaceuticals 2007
|
June 2007 |
£150 |
29 % |
The Top 10 Generics Companies
Strategic insight, growth opportunities and competitive dynamics in the US and Europe
|
January 2006 |
£1495 |
28.5 % |
The Pharmaceutical Market: Jordan
|
February 2007 |
£595 |
28.5 % |
Guide to Pharma Pricing & Reimbursement Systems
Western Europe
|
November 2005 |
£970 |
28.5 % |
Europe IT Spending on Business Intelligence to 2012 Pharmaceutical Technology
|
April 2007 |
£695 |
28.5 % |
EvaluatePharma® Yearbook
Company Performance Tables
|
August 2008 |
£1450 |
28 % |
The Pharmaceutical Market: India
|
February 2007 |
£595 |
28 % |
Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey
|
January 1970 |
£7600 |
28 % |
Cough, Cold and Allergy (Hay Fever) Remedies in Israel
|
July 2008 |
£450 |
28 % |
The Pharmaceutical Market: UK
|
January 2007 |
£595 |
27.5 % |
The Asthma and COPD Market Outlook
Market analysis of future growth and leading players by sector
|
January 2005 |
£1495 |
27.5 % |
India: Pharmaceutical and biotechnology opportunities
|
April 2006 |
£600 |
27.5 % |
Virtual Pharma
The Radical Route To Success
|
September 2008 |
£795 |
27.5 % |
The Pharmaceutical Market: Finland
|
January 2007 |
£595 |
27.5 % |
The Pharmaceutical Market: Greece
|
October 2007 |
£595 |
27.5 % |
Generics Defense Strategies
Effective brand protection through patent, formulation, OTC and DTC strategies
|
January 2005 |
£1495 |
27 % |
Pharmaceutical Branding Strategies
Thought leader perspectives on brand building, effective communication and future brand models
|
January 2006 |
£1495 |
27 % |
Sales Force Effectiveness
Benchmarking the Resources and Structure Required to Service the U.S. Hospital Marketplace
|
June 2006 |
£2315 |
27 % |
Bringing Drugs to Market The role of CRM in improving sales & marketing (Executive Presentation)
|
August 2007 |
£1000 |
27 % |
Global Pharmaceutical Product Lifecycle Management Forecast 2006-2012 (Interactive Model)
|
July 2007 |
£7895 |
27 % |
Philips Medical Systems Medical Device Company Intelligence Report
|
December 2005 |
£295 |
27 % |
Project Management for the Pharmaceutical Industry
|
September 2004 |
£75 |
27 % |
China Pharmaceuticals 2005
|
October 2005 |
£150 |
26.5 % |
China Biopharmaceutical Industry Report, 2006-2007
|
March 2007 |
£200 |
26 % |
U.S. Market for Gastrointestinal Pharmaceuticals
|
September 2005 |
£3045 |
26 % |
Worldwide Prescription Drug Market for Women’s Health
Now and Future 2004-2009
|
February 2001 |
£880 |
26 % |
Business Trends: Pharmaceutical Technology
Understanding your Pharmaceutical Customer (Customer Focus)
|
December 2007 |
£1795 |
26 % |
Generics will play an increasingly important role in the pharma industry
|
October 2006 |
£895 |
26 % |
Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets
Reshaping Tomorrow's Diabetes Market
|
October 2005 |
£1340 |
26 % |
Major Pharmaceutical Markets of the Middle East
An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE
|
April 2006 |
£799 |
25.9 % |
Modern Biopharmaceuticals
Design, Development and Optimization, 4 Volumes
|
September 2005 |
£440 |
25.5 % |
The Pharmaceutical Market: Hungary
|
February 2007 |
£595 |
25.5 % |
Cross industry collaboration
Evaluating future synergies among Pharma/Medical Device/Diagnostics sectors
|
October 2004 |
£2335 |
25.5 % |
The Pharmaceutical Market: Belgium
|
October 2006 |
£595 |
25.5 % |
Who's Developing What in Drug Delivery?
|
October 2006 |
£495 |
25.5 % |
The Pharmaceutical Market: Spain
|
October 2007 |
£595 |
25.5 % |
The Antivirals Market Outlook
Market analysis of future growth and leading players by sector
|
January 2005 |
£1495 |
25.5 % |
Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012 (Databook)
|
July 2007 |
£695 |
25 % |
Pharmaceutical Product Lifecycle Management Forecast in North America 2006-2012 (Databook)
|
July 2007 |
£695 |
25 % |
Snapshots Ukraine Pharmaceuticals 2005
|
November 2005 |
£150 |
25 % |
Translational Medicine - Drug Development Transformed? (Market Focus)
Drug Development Transformed? (Market Focus)
|
February 2007 |
£947 |
25 % |
Protein Drug Delivery: Penetrating a Growth Market
|
March 2005 |
£4000 |
25 % |
Pharmaceutical Biotechnology
Drug Discovery and Clinical Applications
|
February 2004 |
£115 |
25 % |
Commercial Insight: Antihypertensives
New challenges for a maturing market
|
September 2006 |
£8000 |
25 % |
Commercial Insight: Antihormonal Therapy Cancer Brands
Careful Lifecycle Management Needed to Preserve Brand Dominance
|
August 2008 |
£7600 |
25 % |
Argentina Pharmaceuticals 2005
|
October 2005 |
£150 |
25 % |
The Cancer Market Outlook to 2010
|
January 2005 |
£1495 |
24.5 % |
Snapshots Japan Pharmaceuticals 2007
|
April 2007 |
£150 |
24.5 % |
Smoking Cessation and Addiction Treatments
A World Market Analysis
|
April 2007 |
£1005 |
24.5 % |
Pharmaceutical Product Lifecycle Management Forecast in Western Europe 2006-2012 (Databook)
|
July 2007 |
£695 |
24.5 % |
Snapshots China Pharmaceuticals 2005
|
October 2005 |
£150 |
24.5 % |
hERG Screening
|
January 2008 |
£1980 |
24.5 % |
Animal Health Products Antibacterials Markets
|
May 2008 |
£1340 |
24.5 % |
Snapshots Argentina Pharmaceuticals 2005
|
October 2005 |
£150 |
24.5 % |
The Outlook for Pharmaceuticals in Central & Eastern Europe
|
March 2007 |
£1995 |
24.5 % |
Japan Pharmaceuticals 2005
|
October 2005 |
£150 |
24.5 % |
The Outlook for Pharmaceuticals in Western Europe
|
March 2007 |
£1995 |
24.15 % |
The Chinese Pharmaceutical Directory 2008
How to keep up-to-date with China's Pharmaceutical businesses and discover hundreds of new business leads
|
November 2007 |
£230 |
24 % |
Brazil Pharmaceuticals 2005
|
October 2005 |
£150 |
24 % |
High-Content Screening and Implications for IT
|
January 2005 |
£1945 |
24 % |
Global BioGenerics Market in 2010, The
A Consensus Market Models report
|
November 2005 |
£495 |
24 % |
Spain Pharmaceuticals 2005
|
October 2005 |
£150 |
24 % |
Snapshots Ukraine Pharmaceuticals 2007
|
May 2007 |
£150 |
24 % |
Pfizer - Market Outlook for a Global Leader, 2008-2013
|
August 2008 |
£2999 |
24 % |
Pharma Poland News
Newsletter
|
April 2006 |
£795 |
23.8 % |
Global Pharmaceuticals and Medicine Manufacturing
IBISWorld Industry Report
|
September 2007 |
£505 |
23.5 % |
Global Pharmaceuticals and Medicine Manufacturing
IBISWorld Industry Report
|
September 2007 |
£250 |
23.5 % |
Snapshots Poland Pharmaceuticals 2007
|
August 2007 |
£150 |
23.5 % |
Genomics World Markets
|
May 2008 |
£2280 |
23.5 % |
Snapshots Spain Pharmaceuticals 2007
|
June 2007 |
£150 |
23.5 % |
Takeda: PharmaVitae Profile
PharmaVitae Profile
|
October 2006 |
£3000 |
23.5 % |
Global Pharmaceutical Fine Chemicals
Industry and market analysis
|
July 2004 |
£925 |
23.5 % |
The Women's Health Market Outlook to 2011
|
April 2007 |
£1495 |
23.5 % |
New Drug Futures: Central Nervous System Chapter
|
May 2006 |
£695 |
23.5 % |
Commercial Insight: CNS Market Overview
Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors
|
April 2008 |
£8000 |
23.5 % |
Pharmaceutical Product Approval Trends, 2007
Key Market Benchmarks And Strategic Insights
|
December 2007 |
£1299 |
23.5 % |
PharmaVitae 2005: Almirall Global Analysis
|
August 2005 |
£2000 |
23.5 % |
Snapshots Spain Pharmaceuticals 2007
|
June 2007 |
£150 |
23.5 % |
Snapshots Spain Pharmaceuticals 2007
|
June 2007 |
£150 |
23.5 % |
Snapshots Japan Pharmaceuticals 2006
|
November 2006 |
£150 |
23.5 % |
The Outlook for Pharmaceuticals in South East Asia
|
March 2007 |
£1995 |
23.1 % |
The Outlook for Pharmaceuticals in Latin America
|
March 2007 |
£1995 |
23.1 % |
New Drug Futures: Alimentary/Metabolic Chapter
|
May 2006 |
£695 |
23 % |
China Medical Market Report (2004)
|
January 2004 |
£1110 |
23 % |
The Global Drug Delivery Market
Research Trends and Market Outlook
|
May 2006 |
£1340 |
23 % |
Snapshots Argentina Pharmaceuticals 2006
|
November 2006 |
£150 |
23 % |
Snapshots UK Pharmaceuticals 2006
|
November 2006 |
£150 |
23 % |
Snapshots Ukraine Pharmaceuticals 2006
|
September 2006 |
£150 |
23 % |
PharmaVitae 2005: Almirall Global and US Analysis
|
August 2005 |
£2000 |
23 % |
Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays
3rd. Edition
|
November 2007 |
£2680 |
23 % |
Snapshots Brazil Pharmaceuticals 2006
|
November 2006 |
£150 |
23 % |
Therapeutic Monoclonal Antibodies, 2006-2011
Maximising the Growth Potential of a Stocked Pipeline
|
December 2006 |
£1999 |
23 % |
Pharmaceutical Wholesale and Distribution Industry Outlook & Analysis 2008, The
|
June 2008 |
£1499 |
23 % |
Snapshots Denmark Pharmaceuticals 2006
|
September 2006 |
£150 |
23 % |
Analysis Report on China Antibiotic Industry
|
June 2007 |
£135 |
23 % |
World Hypertension Market 2005-2010; The
|
November 2005 |
£1799 |
22.5 % |
Pharmaceutical Toxicology (ULLA)
First Edition
|
June 2006 |
£29.95 |
22.5 % |
Pharmaceutical Industry Online
|
January 2004 |
£720 |
22.5 % |
The Biogenerics Market Outlook
An analysis of market dynamics, growth drivers and leading players
|
January 2005 |
£1495 |
22.5 % |
Partnering And Business Trends In Transgenic Manufacturing
|
January 2004 |
£95 |
22.5 % |
Snapshots Mexico Pharmaceuticals 2007
|
July 2007 |
£150 |
22.5 % |
Snapshots Brazil Pharmaceuticals 2007
|
July 2007 |
£150 |
22.5 % |
DNA/RNA Therapies
Translating the Genome into a $1.2bn Market by 2010
|
February 2005 |
£4000 |
22.5 % |
Excipients in Pharmaceuticals
|
June 2001 |
£3255 |
22.5 % |
New Drug Futures: Vaccines Chapter
|
May 2006 |
£695 |
22.5 % |
Cancer Market Top 20 Drugs
Supportive Care Grows the Cancer Market
|
January 2005 |
£8000 |
22.5 % |
The Outlook for Pharmaceuticals in Northern Europe
|
March 2007 |
£1995 |
22.4 % |
Urinary Incontinence Markets
Sector Snapshot
|
January 2006 |
£335 |
22 % |
PharmaHandbook: Middle East & Africa
A Guide to the International Pharmaceutical Industry
|
June 2004 |
£125 |
22 % |
Web Logs ('Blogs') and the Pharmaceutical Industry
|
January 2006 |
£2195 |
22 % |
PharmaHandbook: Asia, Pacific
A Guide to the International Pharmaceutical Industry
|
June 2004 |
£125 |
22 % |
PharmaHandbook: European Union (EU)
A Guide to the International Pharmaceutical Industry
|
June 2004 |
£125 |
22 % |
Snapshots China Pharmaceuticals 2007
|
March 2007 |
£150 |
22 % |
China’s Guidebook for Pharmaceutical Patent Protection
|
June 2008 |
£1005 |
22 % |
Transdermal Drug Delivery
Technologies, Markets, and Companies
|
September 2008 |
£1675 |
22 % |
Biosimilars
Evolution or Revolution
|
September 2006 |
£1950 |
22 % |
Launch Strategies - Analyzing Market Trends and Regulatory Impacts
|
August 2007 |
£8010 |
22 % |
Monoclonal Antibody Therapies 2004
Entering A New Competitive Era
|
May 2004 |
£1510 |
22 % |
PharmaHandbook: North America
A Guide to the International Pharmaceutical Industry
|
June 2004 |
£125 |
22 % |
The Diabetes Market Outlook
Market analysis of future growth and leading players by sector
|
January 2005 |
£1495 |
21.5 % |
Biopharmaceuticals: Biochemistry and Biotechnology
Second Edition
|
July 2003 |
£47.5 |
21.5 % |
Snapshots Poland OTC Pharmaceuticals 2007
|
September 2007 |
£0 |
21.5 % |
Snapshots Poland OTC Pharmaceuticals 2007
|
September 2007 |
£0 |
21.5 % |
Commercial Insight: Antipsychotics
From Blockbuster Brands to Billion Dollar Generics
|
December 2004 |
£8000 |
21.5 % |
Gene Expression Reagents Markets
|
April 2007 |
£1340 |
21.5 % |
The eHealth Market in Japan: Building Physician Loyalty Via Online Tools
|
October 2005 |
£2195 |
21.5 % |
Snapshots Poland OTC Pharmaceuticals 2005
|
December 2005 |
£150 |
21.5 % |
Monoclonal Antibodies 2007
Competitive Landscape & Pipeline Insight
|
January 2007 |
£1510 |
21.5 % |
Snapshots Poland OTC Pharmaceuticals 2007
|
September 2007 |
£150 |
21.5 % |
Market Development in Anti-virals:What is Next?
What is Next?
|
August 2004 |
£415 |
21 |
